Close Menu

NEW YORK (GenomeWeb) – Invitae announced after the close of the market on Monday that it will offer $125 million worth of its common stock in a public offering.

The San Francisco-based genetic testing firm hasn't finalized the number of shares it will offer of the expected offering price. Its shares were trading down around 5 percent at $19.35 on the New York Stock Exchange on Tuesday morning.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.